At team of researchers at MD Anderson Cancer Center has retracted a paper after realizing that the cell lines they were using weren’t what they thought they were.
Here’s the detailed notice: Continue reading Cancer cell line mixup leads to retraction
A fight over who owns tuberculosis study data has led the Journal of Clinical Microbiology to publish an Expression of Concern.
Here’s the notice: Continue reading Spat over tuberculosis study data leads to Expression of Concern
Contemporary Clinical Dentistry has yanked a 2012 article on “full-mouth rehabilitation” after learning that the article had already appeared in two other publications — making the journal, in effect, Contemporaneous Clinical Dentistry.
The article, “Full-mouth rehabilitation of a patient with severe attrition using the Hobo Twin-Stage Procedure,” came from a group at the Dr. R. Ahmed Dental College, in Kolkata, India. It described the following case: Continue reading Dental journal pulls paper for duplicate publication
Holy Chutzpah, Batman! A team of researchers in India has retracted their 2012 paper in PLoS One on botulinum toxin for plagiarism — while blaming the journal for failing to use its “soft wares” to catch the plagiarism.
The article, “Small-Molecule Quinolinol Inhibitor Identified Provides Protection against BoNT/A in Mice,” was written by a group from the Defence Research and Development Establishment, in Madhya Pradesh.
According to the retraction notice: Continue reading Chutzpah: Authors blame PLOS ONE for failing to find plagiarism in paper on Botulinum toxin
In 2005, Barbara Fredrickson and Marcial Losada published a paper in American Psychologist making a bold and specific claim:
…the authors predict that a ratio of positive to negative affect at or above 2.9 will characterize individuals in flourishing mental health.
The paper made quite a splash. It has been cited 360 times, according to Thomson Scientific’s Web of Knowledge, and formed the basis of a 2009 book by Fredrickson, Positivity: Top-Notch Research Reveals the 3 to 1 Ratio That Will Change Your Life.
But something didn’t sit right with Nick Brown, a psychology grad student at the University of East London. He found the paper’s claims wanting, and contacted Alan Sokal — yes, that Alan Sokal, who published a fake paper in Social Text in 1996. Sokal agreed, and he, Brown, and Harris Friedman published a critique of the paper in July of this year in American Psychologist. Its abstract: Continue reading Fredrickson-Losada “positivity ratio” paper partially withdrawn
We’ll say it again: We like being able to point out when researchers stand up and do the right thing, even at personal cost.
In December 2011, Pamela C. Ronald, of the University of California, Davis, and colleagues published a paper in PLOS ONE,”Small Protein-Mediated Quorum Sensing in a Gram-Negative Bacterium.” Such quorum sensing research is a “hot topic” right now, so not surprisingly the paper caught the attention of other scientists, and the media, including the Western Farm Press. The study has been cited eight times, according to Thomson Scientific’s Web of Knowledge.
One of those scientists who took notice was Ronald’s UC Davis colleague Jonathan Eisen, who posted about the paper on his blog. That was on January 9, 2012. But if you go to that post today, you’ll see that Eisen struck through most of it, and added this comment: Continue reading Doing the right thing: Researchers retract quorum sensing paper after public process
Last month, we reported on a retraction in Judgment and Decision Making that said “problems were discovered with the data.” At the time, corresponding author Wen-Bin Chiou, of National Sun Yat-sen University in Taiwan, told us that a research assistant who had since left the lab hadn’t kept questionnaires used in the research, making replication impossible.
But it turns out that wasn’t the whole story of “Shame for money: Shame enhances the incentive value of economic resources,” to put it charitably. We’ve now heard from people familiar with the case and can provide a fuller account.
The problems with the paper, according to our source, Continue reading Real problems with retracted shame and money paper revealed
CHICAGO — Almost two years after editors at 18 journals agreed in March 2011 to retract 88 of former retraction record holder Joachim Boldt’s papers, 10% of them hadn’t been retracted.
That’s what Nadia Elia, Liz Wager, and Martin Tramer reported here Sunday in an abstract at the Seventh International Congress on Peer Review and Biomedical Publication. Elia and Tramer are editors at the European Journal of Anaesthesiology, while Wager is former chair of the Committee on Publication Ethics (COPE).
As of January 2013, nine of the papers hadn’t been retracted, Tramer said, while only five — all in one journal — had completely followed COPE guidelines, with adequate retraction notices, made freely available, along with PDFs properly marked “Retracted.” From the abstract (see page 18): Continue reading What happened to Joachim Boldt’s 88 papers that were supposed to be retracted?
A group of researchers at the Einstein College of Medicine in the Bronx, New York has retracted two papers for image manipulation.
The retraction notices for “PM02734 (Elisidepsin) Induces Caspase-Independent Cell Death Associated with Features of Autophagy, Inhibition of the Akt/mTOR Signaling Pathway, and Activation of Death-Associated Protein Kinase” and “The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells from EGFR Inhibition by Erlotinib and Cetuximab” say the same thing: Continue reading Papers on potential cancer drugs retracted for image manipulation
The Lancet has retracted a study of Novartis’ blood pressure drug valsartan (Diovan) that has been subject to an investigation following the retraction of a related study earlier this year.
Continue reading Lancet retracts Jikei Heart Study of valsartan following investigation